Jones D P, Sosa F R, Shartsis J, Shah P T, Skromak E, Beher W T
J Clin Invest. 1971 Feb;50(2):259-65. doi: 10.1172/JCI106490.
Patients with acute hepatitis and chronic alcoholic liver disease had decreased net serum cholesterol esterifying activity (CEA) which correlated positively with the percentages and concentrations of cholesteryl esters in their serum. These cholesterol parameters also correlated negatively with serum bilirubin concentrations, but bilirubin added to sera in vitro failed to influence CEA. The decreased net CEA in the patients was not due to its inhibition by serum bile salts. The sera from five patients catalyzed a net hydrolysis of cholesteryl esters rather than a net esterification of free cholesterol. Since serum cholesteryl ester hydrolase activity may also have been present in the patients with decreased CEA, net CEA cannot be equated with the activity of lecithin-cholesterol acyl transferase (LCAT) in patients with liver disease. The relative contributions of LCAT and cholesteryl ester hydrolase activities to CEA in disease states remain to be evaluated by mutually independent assays. Nevertheless, the correlations found between net CEA and the concentrations and percentages of cholesteryl esters support the concepts that serum cholesterol esterifying activity is physiologically important in the formation of serum cholesteryl esters and that decreased CEA is one mechanism for the decreased level of cholesteryl esters seen in patients with liver diseases.
急性肝炎和慢性酒精性肝病患者的血清胆固醇酯化活性(CEA)净值降低,该活性与血清中胆固醇酯的百分比和浓度呈正相关。这些胆固醇参数也与血清胆红素浓度呈负相关,但体外向血清中添加胆红素未能影响CEA。患者CEA净值降低并非由于血清胆汁盐对其产生抑制作用。五名患者的血清催化了胆固醇酯的净水解,而非游离胆固醇的净酯化。由于CEA降低的患者血清中可能也存在胆固醇酯水解酶活性,因此在肝病患者中,不能将CEA净值等同于卵磷脂胆固醇酰基转移酶(LCAT)的活性。在疾病状态下,LCAT和胆固醇酯水解酶活性对CEA的相对贡献仍有待通过相互独立的检测进行评估。尽管如此,CEA净值与胆固醇酯浓度和百分比之间的相关性支持了以下观点:血清胆固醇酯化活性在血清胆固醇酯的形成过程中具有重要生理意义,而CEA降低是肝病患者血清胆固醇酯水平降低的一种机制。